Found 5 matching trials
Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer PHASE2 This is an open-label, phase 2, randomized study of intravesical N-803 plus...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer PHASE1 This is a Phase Ib/IIb, randomized, two-cohort, open-label, multicenter stu...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer PHASE2 This is a Phase II/III, open-label, single-arm, multicenter study of intrav...
Show More Status
Active Not Recruiting
Location
Alaska Clinical Research Center
Learn More & Join Trial
Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC) N/A The purpose of this clinical trial is to obtain long-term follow-up informa...
Show More Status
Active Not Recruiting
Learn More & Join Trial
PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14) N/A Non-interventional PK sub-study of QUILT-3.032 (CA-ALT-803-01-16) and QUILT...
Show More Location
UCLA Department of Urology
Learn More & Join Trial